International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.08 and traded as high as $0.11. International Stem Cell shares last traded at $0.11, with a volume of 3,750 shares.
International Stem Cell Stock Performance
The firm has a 50 day moving average of $0.10 and a two-hundred day moving average of $0.08.
About International Stem Cell
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Read More
- Five stocks we like better than International Stem Cell
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- 3 Warren Buffett Stocks to Buy Now
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- What is a SEC Filing?
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
